Skip to main content

Emily Olsen

By Emily Olsen | 12:40 pm | March 08, 2023
Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.
By Emily Olsen | 03:51 pm | March 07, 2023
According to a filing with the Securities and Exchange Commission, the company still plans to hire "to support its service capacity needs and growth expectations."
By Emily Olsen | 01:10 pm | March 07, 2023
The partnership marks another move in home care for the retail giant, which has made several acquisitions in the space over the past few years.
By Emily Olsen | 01:33 pm | March 06, 2023
Transcarent will purchase 98point6's virtual care platform and care business. After the deal, 98point6 will focus on licensing its software to third-party providers.
By Emily Olsen | 11:56 am | March 03, 2023
In a post on LinkedIn, Color CEO Othman Laraki said the company would focus on its core lines of business, including testing and telehealth infrastructure for government programs, and its prevention tools for employers and healthcare purchasers.
By Emily Olsen | 11:13 am | March 03, 2023
Scott Loughlin, partner at Hogan Lovells, discusses the Federal Trade Commission's recent enforcement action against GoodRx and what digital health companies should learn from the case.
By Emily Olsen | 01:58 pm | March 02, 2023
In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.
By Emily Olsen | 05:36 pm | March 01, 2023
The digital health company reported $184.1 million in revenue for Q4, a 14% decline from the same period in 2021.
By Emily Olsen | 12:19 pm | March 01, 2023
The wearable uses its motion sensors to determine if the user has taken a hard fall and can contact emergency services if they don't respond.
By Emily Olsen | 11:16 am | March 01, 2023
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.